Propulsé par l'IA avec sources citées
NewzBitsComprehensive coverage and timeline for Nasal Spray. Aggregated from 4 sources with 4 articles.
4 articles · 4 sources · Couverture depuis 4/1/2026
L'évolution de la couverture de Nasal Spray au fil du temps.
Image : Texas A&M University• Texas A&M researchers developed a nasal spray therapy that reverses brain aging by healing inflammation and restoring memory function. • The treatment targets age-related cognitive decline, turning 'brain fog to brain focus' in preclinical models. • Announced on April 14, 2026, it reshapes future therapies for neurodegenerative diseases.
stories.tamu.edu• FDA approved Haleon's Narcan 4mg nasal spray for non-prescription sale on April 7, 2026, building on 2023 authorization. • Reversal success rate 98% in trials with 150 US overdose simulations; priced at $29.95 for two-pack. • Addresses 110,000 annual US opioid deaths; 'Lifeline for bystanders,' says FDA Commissioner.
bloomberg.comNSW follows Queensland, South Australia and Western Australia in offering free treatments for kids four and under, saving up to $70Get our breaking news email, free app or daily news podcastHundreds of thousands of children will be able to access a painless, needle-free flu vaccination for free as governments attempt to curb falling vaccine rates.New South Wales has become the latest state to offer a nasal spray flu vaccine to children for free, following Queensland, South Australia and Western Australia. Continue reading...
theguardian.com• Express Scripts added CARDAMYST (etripamil) nasal spray to its commercial national formularies effective March 27, 2026, expanding access for commercially insured patients. • The FDA-approved self-administered spray converts acute paroxysmal supraventricular tachycardia (PSVT) episodes to sinus rhythm in adults. • This coverage decision makes the first-in-class treatment broadly affordable across the U.S., improving cardiovascular care options.
investors.milestonepharma.com